Graham R M, Hess H J, Homcy C J
Proc Natl Acad Sci U S A. 1982 Apr;79(7):2186-90. doi: 10.1073/pnas.79.7.2186.
The highly selective alpha 1-adrenergic receptor antagonist prazosin was used to identify binding sites having alpha-adrenergic specificity in rat hepatic plasma membranes. Solubilization of the membrane-bound receptors was achieved by incubation with the nonionic detergent digitonin, and binding activity was assayed by using [3H]prazosin and a polyethylene glycol precipitation technique. Only 20-30% of the total receptor pool was released by the solubilization procedure. However, binding of [3H]prazosin was saturable [maximal value, 206 +/- 8 fmol/mg of protein (membrane) vs. 74 +/- 4 fmol/mg of protein (soluble)] and of high affinity [Kd, 0.6 +/- 0.2 nM (membrane) vs. 0.8 +/- 0.2 nM (soluble)]. To aid in purification of the receptors, an affinity resin was developed using an analog of prazosin, 2-(4-succinoylpiperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline (CP 57,609; Kd 2.7 X 10(-7) M) immobilized via an amide linkage to agarose. The resulting resin demonstrated high affinity (Kd 3.2 X 10(-7) M) for the solubilized receptors, as determined by competitive inhibition assay. The degree of substitution to the resin was determined by a direct radioimmunoassay using antibodies against albumin-complexed CP 57,609 and found to be 0.1 to 0.2 mumol/ml of agarose. Affinity chromatography using the resin resulted in 513-fold purification in a single step. Moreover, the specificity of the purified binding sites was similar to that of membrane-bound receptors. This novel affinity resin should thus provide a powerful tool for isolating the receptor protein in quantities sufficient for detailed biochemical characterization.
高选择性α1-肾上腺素能受体拮抗剂哌唑嗪被用于鉴定大鼠肝细胞膜中具有α-肾上腺素能特异性的结合位点。通过与非离子去污剂洋地黄皂苷孵育实现膜结合受体的溶解,并使用[3H]哌唑嗪和聚乙二醇沉淀技术测定结合活性。溶解过程仅释放了总受体池的20%-30%。然而,[3H]哌唑嗪的结合是可饱和的[最大值,206±8 fmol/mg蛋白质(膜)对74±4 fmol/mg蛋白质(可溶性)]且具有高亲和力[解离常数(Kd),0.6±0.2 nM(膜)对0.8±0.2 nM(可溶性)]。为了辅助受体的纯化,使用哌唑嗪类似物2-(4-琥珀酰哌嗪-1-基)-4-氨基-6,7-二甲氧基喹唑啉(CP 57,609;Kd 2.7×10−7 M)通过酰胺键固定在琼脂糖上制备了一种亲和树脂。通过竞争性抑制试验测定,所得树脂对溶解的受体显示出高亲和力(Kd 3.2×10−7 M)。通过使用针对白蛋白复合CP 57,609的抗体的直接放射免疫测定法确定树脂的取代度,发现为0.1至0.2 μmol/ml琼脂糖。使用该树脂进行亲和层析可在一步中实现513倍的纯化。此外,纯化的结合位点的特异性与膜结合受体的特异性相似。因此,这种新型亲和树脂应为分离足够量的受体蛋白以进行详细的生化表征提供强大工具。